Thallium-201 chloride
Thallium-201 chloride is a radiopharmaceutical used primarily in cardiac imaging.
Characteristics
- photon energy: 80 keV
- physical half life: 73 hours
- biological half life
- rest: 3 minutes
- exercise: 30 seconds
- normal distribution: myocardium, skeletal muscle, GI tract, liver, kidneys
- excretion: renal
- target organ: kidneys
- pharmacokinetics:
- miscellaneous facts:
- more background noise than MUGA
- 201Tl-cerebral SPECT can be used to differentiate toxoplasmosis vs lymphoma (increased uptake in lymphoma, decreased in toxoplasmosis)
Uses, doses and timings
Cardiac Scan
- adult dose: 55.5 MBq (1.5 mCi) IV
Related Radiopaedia articles
Physics and imaging technology: nuclear medicine
- radioactivity
- atomic structure
- isotopes
- radioactive decay
- alpha decay
- beta decay
- electron capture decay
- gamma decay
- half life
- decay activity
- detectors
-
radiopharmaceuticals
- fundamentals of radiopharmaceuticals
- radiopharmaceutical labeling
- radiopharmaceutical production
- nuclear reactor produced radionuclides
- cyclotron produced radionuclides
- radiation detection
- dosimetry
- specific agents
- carbon-11
- chromium-51
- fluorine-18 FDG
- gallium agents
- Ga-67 citrate
- Ga-68
- iodine agents
-
I-123
- I-123 iodide
- I-123 ioflupane (DaTSCAN)
- I-123 ortho-iodohippurate
- I-131
-
MIBG scans
- I-123 MIBG
- I-131 MIBG
-
I-123
- indium agents
- In-111 Octreoscan
- In-111 OncoScint
- In-111 Prostascint
- In-111 oxine labeled WBC
- krypton-81m
- nitrogen-13
- oxygen-15
- phosphorus-32
- selenium-75
-
technetium agents
- technetium-99m DMSA
- technetium-99m DTPA
- technetium-99m DTPA aerosol
- technetium-99m HMPAO
- technetium-99m HMPAO labeled WBC
- technetium-99m MAA
- technetium-99m MAG3
- technetium-99m MDP
- technetium-99m mercaptoacetyltriglycine
- technetium-99m pertechnetate
- technetium-99m labeled RBC
- technetium-99m sestamibi
- technetium-99m sulfur colloid
- technetium-99m sulfur colloid (oral)
- thallium-201 chloride
- xenon-127
- xenon-133
- in vivo therapeutic agents
- pharmaceuticals used in nuclear medicine